CVS to pay almost $37 million to settle switching of ranitidine
CVS reaches $36.7 million settlement agreement on retail dispensing practices for ranitidine.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
